KKR’s Gamma Biosciences to sell Astrea Bioseparations to Biotage

Gamma's sale of Astrea will be in exchange for newly issued shares in Biotage.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this